Protein Science
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elliott, P. R.
Right arrow Articles by Lomas, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elliott, P. R.
Right arrow Articles by Lomas, D. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Protein Science, Vol 9, Issue 7 1274-1281, Copyright © 2000 by The Protein Society


Topography of a 2.0 A structure of alpha1-antitrypsin reveals targets for rational drug design to prevent conformational disease [In Process Citation]

PR Elliott, XY Pei, TR Dafforn and DA Lomas
Department of Medicine, University of Cambridge, The Wellcome Trust Centre for Molecular Mechanisms in Disease, Cambridge Institute for Medical Research, United Kingdom.

Members of the serpin family of serine proteinase inhibitors play important roles in the inflammatory, coagulation, fibrinolytic, and complement cascades. An inherent part of their function is the ability to undergo a structural rearrangement, the stressed (S) to relaxed (R) transition, in which an extra strand is inserted into the central A beta-sheet. In order for this transition to take place, the A sheet has to be unusually flexible. Malfunctions in this flexibility can lead to aberrant protein linkage, serpin inactivation, and diseases as diverse as cirrhosis, thrombosis, angioedema, emphysema, and dementia. The development of agents that control this conformational rearrangement requires a high resolution structure of an active serpin. We present here the topology of the archetypal serpin alpha1-antitrypsin to 2 A resolution. This structure allows us to define five cavities that are potential targets for rational drug design to develop agents that will prevent conformational transitions and ameliorate the associated disease.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Protein Sci.Home page
M. C. Pearce, C. J. Morton, S. C. Feil, G. Hansen, J. J. Adams, M. W. Parker, and S. P. Bottomley
Preventing serpin aggregation: The molecular mechanism of citrate action upon antitrypsin unfolding
Protein Sci., December 1, 2008; 17(12): 2127 - 2133.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Klieber, C. Underhill, G. L. Hammond, and Y. A. Muller
Corticosteroid-binding Globulin, a Structural Basis for Steroid Transport and Proteinase-triggered Release
J. Biol. Chem., October 5, 2007; 282(40): 29594 - 29603.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
J.-H. Baek, H. Im, U.-B. Kang, K. M. Seong, C. Lee, J. Kim, and M.-H. Yu
Probing the local conformational change of {alpha}1-antitrypsin
Protein Sci., September 1, 2007; 16(9): 1842 - 1850.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Y.-P. Chang, R. Mahadeva, W.-S. W. Chang, A. Shukla, T. R. Dafforn, and Y.-H. Chu
Identification of a 4-mer Peptide Inhibitor that Effectively Blocks the Polymerization of Pathogenic Z {alpha}1-Antitrypsin
Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 540 - 548.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Tong and M. R. Kanost
Manduca sexta Serpin-4 and Serpin-5 Inhibit the Prophenol Oxidase Activation Pathway: cDNA CLONING, PROTEIN EXPRESSION, AND CHARACTERIZATION
J. Biol. Chem., April 15, 2005; 280(15): 14923 - 14931.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Tong, H. Jiang, and M. R. Kanost
Identification of Plasma Proteases Inhibited by Manduca sexta Serpin-4 and Serpin-5 and Their Association with Components of the Prophenol Oxidase Activation Pathway
J. Biol. Chem., April 15, 2005; 280(15): 14932 - 14942.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Onda, D. Belorgey, L. K. Sharp, and D. A. Lomas
Latent S49P Neuroserpin Forms Polymers in the Dementia Familial Encephalopathy with Neuroserpin Inclusion Bodies
J. Biol. Chem., April 8, 2005; 280(14): 13735 - 13741.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
D A Lomas and H Parfrey
{alpha}1-Antitrypsin deficiency * 4: Molecular pathophysiology
Thorax, June 1, 2004; 59(6): 529 - 535.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Parfrey, R. Mahadeva, N. A. Ravenhill, A. Zhou, T. R. Dafforn, R. C. Foreman, and D. A. Lomas
Targeting a Surface Cavity of {alpha}1-Antitrypsin to Prevent Conformational Disease
J. Biol. Chem., August 29, 2003; 278(35): 33060 - 33066.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
C. Green, G. Brown, T. R. Dafforn, J.-M. Reichhart, T. Morley, D. A. Lomas, and D. Gubb
Drosophila necrotic mutations mirror disease-associated variants of human serpins
Development, April 1, 2003; 130(7): 1473 - 1478.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. Brantly
{alpha}1-Antitrypsin: Not Just an Antiprotease: Extending the Half-Life of a Natural Anti-Inflammatory Molecule by Conjugation with Polyethylene Glycol
Am. J. Respir. Cell Mol. Biol., December 1, 2002; 27(6): 652 - 654.
[Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A. M. Cantin, D. E. Woods, D. Cloutier, E. K. Dufour, and R. Leduc
Polyethylene Glycol Conjugation at Cys232 Prolongs the Half-Life of {alpha}1 Proteinase Inhibitor
Am. J. Respir. Cell Mol. Biol., December 1, 2002; 27(6): 659 - 665.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Janciauskiene, R. Dominaitiene, N. H. Sternby, E. Piitulainen, and S. Eriksson
Detection of Circulating and Endothelial Cell Polymers of Z and Wild Type alpha 1-Antitrypsin by a Monoclonal Antibody
J. Biol. Chem., July 12, 2002; 277(29): 26540 - 26546.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. J. Belzar, A. Zhou, R. W. Carrell, P. G. W. Gettins, and J. A. Huntington
Helix D Elongation and Allosteric Activation of Antithrombin
J. Biol. Chem., March 1, 2002; 277(10): 8551 - 8558.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Jankova, S. J. Harrop, D. N. Saunders, J. L. Andrews, K. C. Bertram, A. R. Gould, M. S. Baker, and P. M. G. Curmi
Crystal Structure of the Complex of Plasminogen Activator Inhibitor 2 with a Peptide Mimicking the Reactive Center Loop
J. Biol. Chem., November 9, 2001; 276(46): 43374 - 43382.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
R A PRIMHAK and M S TANNER
Alpha-1 antitrypsin deficiency
Arch. Dis. Child., July 1, 2001; 85(1): 2 - 5.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Mahadeva, T. R. Dafforn, R. W. Carrell, and D. A. Lomas
6-mer Peptide Selectively Anneals to a Pathogenic Serpin Conformation and Blocks Polymerization. IMPLICATIONS FOR THE PREVENTION OF Z alpha 1-ANTITRYPSIN-RELATED CIRRHOSIS
J. Biol. Chem., February 22, 2002; 277(9): 6771 - 6774.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Sivasothy, T. R. Dafforn, P. G. W. Gettins, and D. A Lomas
Pathogenic alpha 1-Antitrypsin Polymers Are Formed by Reactive Loop-beta -Sheet A Linkage
J. Biol. Chem., October 20, 2000; 275(43): 33663 - 33668.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Egelund, A. P. Einholm, K. E. Pedersen, R. W. Nielsen, A. Christensen, J. Deinum, and P. A. Andreasen
A Regulatory Hydrophobic Area in the Flexible Joint Region of Plasminogen Activator Inhibitor-1, Defined with Fluorescent Activity-neutralizing Ligands. LIGAND-INDUCED SERPIN POLYMERIZATION
J. Biol. Chem., April 13, 2001; 276(16): 13077 - 13086.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by The Protein Society.